← Back to catalogue

Spectra WaveWriter™

FDA UDI

Class III (US FDA UDI)

by Boston Scientific Neuromodulation

Identity

Trade Name
Spectra WaveWriter™ FDA UDI
Generic Name
Trial spinal cord/peripheral nerve percutaneous analgesic electrical stimulation system pulse generator FDA UDI
Device Name
External Trial Stimulator FDA UDI
Model / Reference
SC-5160 FDA UDI
Description
External Trial Stimulator FDA UDI

Identifiers

Primary DI / UDI-DI
08714729952046 FDA UDI
PMA Number
P030017 FDA UDI
FDA Product Code
LGW FDA UDI
QRB FDA UDI
GMDN Term
Trial spinal cord/peripheral nerve percutaneous analgesic electrical stimulation system pulse generator FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Trial spinal cord/peripheral nerve percutaneous analgesic electrical stimulation system pulse generator

Spectra WaveWriter™ by Boston Scientific Neuromodulation — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Trial spinal cord/peripheral nerve percutaneous analgesic electrical stimulation system pulse generator.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1590eaef-7be5-4c7f-b37e-17c3dcf09350 34 fields · synced May 30, 2026